Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology
Fusion imaging depicts an innovative technique that facilitates combining assets and reducing restrictions of advanced ultrasound and cross-sectional imaging. The purpose of the present retrospective study was to evaluate the role of fusion imaging for assessing hepatic and renal lesions. Between 02...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2821 |
id |
doaj-4c702d1648cd415d9066720d054198f4 |
---|---|
record_format |
Article |
spelling |
doaj-4c702d1648cd415d9066720d054198f42020-11-25T03:27:42ZengMDPI AGCancers2072-66942020-09-01122821282110.3390/cancers12102821Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in OncologyVincent Schwarze0Johannes Rübenthaler1Constantin Marschner2Matthias Philipp Fabritius3Johannes Rueckel4Nicola Fink5Daniel Puhr-Westerheide6Eva Gresser7Matthias Frank Froelich8Moritz Ludwig Schnitzer9Nils Große Hokamp10Saif Afat11Michael Staehler12Thomas Geyer13Dirk-André Clevert14Department of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyInstitute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University Cologne, Kerpener Str. 62, 50937 Cologne, GermanyDepartment for Diagnostic and Interventional Radiology, Eberhard Karls University Tuebingen, University Hospital Tuebingen, Hoppe-Seyler-Str. 3, 72076 Tuebingen, GermanyDepartment of Urology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyDepartment of Radiology, University Hospital LMU, Marchioninistrasse 15, 81377 Munich, GermanyFusion imaging depicts an innovative technique that facilitates combining assets and reducing restrictions of advanced ultrasound and cross-sectional imaging. The purpose of the present retrospective study was to evaluate the role of fusion imaging for assessing hepatic and renal lesions. Between 02/2011–08/2020, 92 patients in total were included in the study, of which 32 patients had hepatic lesions, 60 patients had renal lesions. Fusion imaging was technically successful in all patients. No adverse side effects upon intravenous (i.v.) application of <i>SonoVue<sup>®</sup></i> (<i>Bracco</i>, Milan, Italy) were registered. Fusion imaging could clarify all 11 (100%) initially as indeterminate described hepatic lesions by computed tomography/magnetic resonance imaging (CT/MRI). Moreover, 5/14 (36%) initially suspicious hepatic lesions could be validated by fusion imaging, whereas in 8/14 (57%), malignant morphology was disproved. Moreover, fusion imaging allowed for the clarification of 29/30 (97%) renal lesions initially characterized as suspicious by CT/MRI, of which 19/30 (63%) underwent renal surgery, histopathology revealed malignancy in 16/19 (84%), and benignity in 3/19 (16%). Indeterminate findings could be elucidated by fusion imaging in 20/20 (100%) renal lesions. Its accessibility and repeatability, even during pregnancy and in childhood, its cost-effectiveness, and its excellent safety profile, make fusion imaging a promising instrument for the thorough evaluation of hepatic and renal lesions in the future.https://www.mdpi.com/2072-6694/12/10/2821fusion imagingultrasoundCEUSCTMRIkidney |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vincent Schwarze Johannes Rübenthaler Constantin Marschner Matthias Philipp Fabritius Johannes Rueckel Nicola Fink Daniel Puhr-Westerheide Eva Gresser Matthias Frank Froelich Moritz Ludwig Schnitzer Nils Große Hokamp Saif Afat Michael Staehler Thomas Geyer Dirk-André Clevert |
spellingShingle |
Vincent Schwarze Johannes Rübenthaler Constantin Marschner Matthias Philipp Fabritius Johannes Rueckel Nicola Fink Daniel Puhr-Westerheide Eva Gresser Matthias Frank Froelich Moritz Ludwig Schnitzer Nils Große Hokamp Saif Afat Michael Staehler Thomas Geyer Dirk-André Clevert Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology Cancers fusion imaging ultrasound CEUS CT MRI kidney |
author_facet |
Vincent Schwarze Johannes Rübenthaler Constantin Marschner Matthias Philipp Fabritius Johannes Rueckel Nicola Fink Daniel Puhr-Westerheide Eva Gresser Matthias Frank Froelich Moritz Ludwig Schnitzer Nils Große Hokamp Saif Afat Michael Staehler Thomas Geyer Dirk-André Clevert |
author_sort |
Vincent Schwarze |
title |
Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology |
title_short |
Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology |
title_full |
Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology |
title_fullStr |
Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology |
title_full_unstemmed |
Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology |
title_sort |
advanced fusion imaging and contrast-enhanced imaging (ct/mri–ceus) in oncology |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2020-09-01 |
description |
Fusion imaging depicts an innovative technique that facilitates combining assets and reducing restrictions of advanced ultrasound and cross-sectional imaging. The purpose of the present retrospective study was to evaluate the role of fusion imaging for assessing hepatic and renal lesions. Between 02/2011–08/2020, 92 patients in total were included in the study, of which 32 patients had hepatic lesions, 60 patients had renal lesions. Fusion imaging was technically successful in all patients. No adverse side effects upon intravenous (i.v.) application of <i>SonoVue<sup>®</sup></i> (<i>Bracco</i>, Milan, Italy) were registered. Fusion imaging could clarify all 11 (100%) initially as indeterminate described hepatic lesions by computed tomography/magnetic resonance imaging (CT/MRI). Moreover, 5/14 (36%) initially suspicious hepatic lesions could be validated by fusion imaging, whereas in 8/14 (57%), malignant morphology was disproved. Moreover, fusion imaging allowed for the clarification of 29/30 (97%) renal lesions initially characterized as suspicious by CT/MRI, of which 19/30 (63%) underwent renal surgery, histopathology revealed malignancy in 16/19 (84%), and benignity in 3/19 (16%). Indeterminate findings could be elucidated by fusion imaging in 20/20 (100%) renal lesions. Its accessibility and repeatability, even during pregnancy and in childhood, its cost-effectiveness, and its excellent safety profile, make fusion imaging a promising instrument for the thorough evaluation of hepatic and renal lesions in the future. |
topic |
fusion imaging ultrasound CEUS CT MRI kidney |
url |
https://www.mdpi.com/2072-6694/12/10/2821 |
work_keys_str_mv |
AT vincentschwarze advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT johannesrubenthaler advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT constantinmarschner advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT matthiasphilippfabritius advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT johannesrueckel advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT nicolafink advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT danielpuhrwesterheide advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT evagresser advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT matthiasfrankfroelich advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT moritzludwigschnitzer advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT nilsgroßehokamp advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT saifafat advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT michaelstaehler advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT thomasgeyer advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology AT dirkandreclevert advancedfusionimagingandcontrastenhancedimagingctmriceusinoncology |
_version_ |
1724587655702773760 |